163 related articles for article (PubMed ID: 33032721)
1. Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.
Elbadawi A; Mahtta D; Elgendy IY; Saad M; Krittanawong C; Hira RS; Omer M; Ogunbayo GO; Garratt K; Rao SV; Jneid H
JACC Cardiovasc Interv; 2020 Oct; 13(19):2312-2314. PubMed ID: 33032721
[No Abstract] [Full Text] [Related]
2. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.
Kirtane AJ; Bangalore S
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025
[No Abstract] [Full Text] [Related]
3. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
Li YH; Huang WC; Hwang JJ;
Am J Cardiol; 2020 Sep; 131():133-134. PubMed ID: 32713656
[No Abstract] [Full Text] [Related]
4. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ
Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225
[No Abstract] [Full Text] [Related]
5. Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.
Sudhakar D; Jneid H; Lakkis N; Kayani WT
Am J Cardiol; 2020 Nov; 134():158. PubMed ID: 32841613
[No Abstract] [Full Text] [Related]
6. [Analysis on the efficacy and safety of fibrinolytic therapy in patients with acute ST-segment elevation myocardial infarction during the COVID-19 epidemic].
Wei F; Shuai XX; Chen ZJ; Cao GL; Wang L; Qiu T; Hu T; Wu L; Zhang Q; Huang HX; Zhang YW; Zhu L; Cheng X
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jun; 48(6):472-476. PubMed ID: 32842256
[No Abstract] [Full Text] [Related]
7. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
Bainey KR; Bates ER; Armstrong PW
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038
[No Abstract] [Full Text] [Related]
8. Underutilization of health care for strokes during the COVID-19 outbreak.
Onteddu SR; Nalleballe K; Sharma R; Brown AT
Int J Stroke; 2020 Jul; 15(5):NP9-NP10. PubMed ID: 32478606
[No Abstract] [Full Text] [Related]
9. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties.
Bennett CE; Anavekar NS; Gulati R; Singh M; Kane GC; Sandoval Y; Foley TA; Jaffe AS; Sandhu GS; Bell MR; Askew JW
Mayo Clin Proc; 2020 Jun; 95(6):1107-1111. PubMed ID: 32414550
[No Abstract] [Full Text] [Related]
10. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.
Hamadeh A; Aldujeli A; Briedis K; Tecson KM; Sanz-Sánchez J; Al Dujeili M; Al-Obeidi A; Diez JL; Žaliūnas R; Stoler RC; McCullough PA
Am J Cardiol; 2020 Sep; 131():1-6. PubMed ID: 32732010
[TBL] [Abstract][Full Text] [Related]
11. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction.
Choudry FA; Hamshere SM; Rathod KS; Akhtar MM; Archbold RA; Guttmann OP; Woldman S; Jain AK; Knight CJ; Baumbach A; Mathur A; Jones DA
J Am Coll Cardiol; 2020 Sep; 76(10):1168-1176. PubMed ID: 32679155
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association.
Khalid N; Chen Y; Case BC; Shlofmitz E; Wermers JP; Rogers T; Ben-Dor I; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):946-949. PubMed ID: 32423791
[TBL] [Abstract][Full Text] [Related]
13. Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.
Yerasi C; Case BC; Forrestal BJ; Chezar-Azerrad C; Hashim H; Ben-Dor I; Satler LF; Mintz GS; Waksman R
Cardiovasc Revasc Med; 2020 Aug; 21(8):1024-1029. PubMed ID: 32471712
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.
Nan J; Meng S; Hu H; Jia R; Chen W; Li Q; Zhang T; Song K; Wang Y; Jin Z
Med Sci Monit; 2020 Sep; 26():e927061. PubMed ID: 32938901
[TBL] [Abstract][Full Text] [Related]
15. Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.
Wilson SJ; Connolly MJ; Elghamry Z; Cosgrove C; Firoozi S; Lim P; Sharma R; Spratt JC
Circ Cardiovasc Interv; 2020 Jul; 13(7):e009438. PubMed ID: 32600109
[No Abstract] [Full Text] [Related]
16. Decrease in ST-segment elevation myocardial infarction admissions in Catalonia during the COVID-19 pandemic.
Romaguera R; Ribera A; Güell-Viaplana F; Tomás-Querol C; Muñoz-Camacho JF; Agudelo V;
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):778-780. PubMed ID: 32565077
[No Abstract] [Full Text] [Related]
17. Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.
Lotfi AS; Capatina A; Kugelmass AD
Am J Cardiol; 2020 Sep; 131():132-133. PubMed ID: 32732009
[No Abstract] [Full Text] [Related]
18. The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
Roffi M; Guagliumi G; Ibanez B
Circulation; 2020 Jun; 141(24):1951-1953. PubMed ID: 32315205
[No Abstract] [Full Text] [Related]
19. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center.
Abdelaziz HK; Abdelrahman A; Nabi A; Debski M; Mentias A; Choudhury T; Patel B; Saad M
Am Heart J; 2020 Aug; 226():45-48. PubMed ID: 32497914
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.
Wang N; Zhang M; Su H; Huang Z; Lin Y; Zhang M
J Int Med Res; 2020 Oct; 48(10):300060520966151. PubMed ID: 33108941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
